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0 The Journal of Thoracic and Cardiovince the 1950s, conventional bioprosthetic and mechanical heart valve sub-
stitutes have significantly improved survival and quality of life for millions of
patients. Nevertheless, these replacement devices are subject to serious, still
nsurmounted, shortcomings, among others macroembolic and microembolic
vents, anticoagulation, premature degeneration and failure, functional imperfec-
ion, and lack of growth. Thus, there is an undoubted need for better prostheses.
issue engineering has evolved during the last 20 years as an appealing alternative
ith great promise, bringing into play the application of principles and methods of
ngineering and life science.E1 Understandably, the ultimate goal is to construct a
iving aortic valve substitute equal to the patient’s own native valve. This makes
ense, because the native valve is the optimal solution as a valve mechanism for that
articular position that has developed in an evolutionary process over millions of
ears, an inconceivable period for human beings. For tissue engineering, a thorough
nderstanding of developmental processes, as well as of relationships of structure to
unction, is indispensable. Some issues are touched on in the present study with
egard to semilunar heart valves.
The heart and the valves are the first organs to form during a complex morpho-
enetic process harmonizing with evolving hemodynamic forces.1 In addition to
ransition of endothelial to mesenchymal cells and migration of these cells to form
he endocardial cushions, numerous genes, molecules, signals, and proteins are
nvolved.E2,E3 Of most interest, multipotent neural crest cells migrate to the outflow
ract2 (Figure 1) and semilunar valves,E4,E5 contributing to development.E4 This
rocess follows a finely tuned, albeit vulnerable,E6-E8 biologic concert not yet
ompletely known, which is also true for the molecular mechanisms to maintain
tructural integrity, regeneration, aging, and remodeling in response to dynamic
nvironmental factors.3 How do cells differentiate at the right time, to the right
xtent, into the right type, and in the right position? What is the control mechanism?
s the neural system the major player during development?
Understanding of not only molecular mechanisms but also details of macrostruc-
ures and microstructures is important for engineering functional equivalents.E9 The
ortic valve is integrated in the aortic root, forming the structural and dynamic
ontinuity between the left ventricle and ascending aorta. It is composed of the
eaflets, the crown-shaped annulus, intervalvular trigones, sinuses of Valsalva,
ommissures, and the sinotubular junction. All components are in close relationship
nd cross-talk among each other, the environment, and the whole body during
ynamic, cyclic function,4 warranting undisturbed unidirectional flow. None of
hese components stands alone. Novel visualization techniques have revealed the
ortic valve leaflets to have a highly complex multilayer mesostructure, providing
nisotropic mechanical behavior that differs distinctly from the currently known
hree-layer morphology.5 Endoscopic and microscopic evaluation of the pressure-
oaded porcine root has shown strong collagen fibers with smaller connecting fibers
mbedded in hammock-shaped, thin membranes in between (Figure 2), which is a
erfect blueprint for suspension bridges. Furthermore, the crimped design of fibers
llows stress compensation. Nerve fibers, a complex pattern of extracellular matrix
omponents, and different interstitial and endothelial cellular phenotypes have been
dentified. They control the transformation of structural, secretory, mitogenic, con-
ractile, and remodeling shear stress stimuliE10 –E15 (Figure 3).
ascular Surgery ● July 2007
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LThese are only some of already known characteristics of
he seemingly simple aortic valve, foreshadowing the in-
redible variability and complexity of this small organ in
articular and of nature in general. Once we are aware of
his complexity, it becomes clear why it is so difficult to
ecapitulate biologic processes by tissue engineering, why
here are so many scientific approaches, and why it takes so
uch time. After two decades of research in this field at a
ost of roughly $4.5 billion, remarkable scientific results
ave indeed been achieved6; however, fewer than 10 tissue-
ngineered products have made it to the clinical setting.E16
ltogether, tissue engineering a copy of a patient’s specific
ative valve hardly seems possible at present. But on the
ay to this ultimate goal, knowledge has already increased
nd will continue to increase, aiding the production of more
iomimetic, improved valve substitutes for clinical use.
In this issue, Hayashida and colleagues7 present their
espectable results on development of an in vivo tissue-
ngineered autologous heart valve (biovalve) and their prep-
ration of a prototype. A special mold consisting of a
ilicone rod and a crown-shaped tubular polyurethane scaf-
old was implanted subcutaneously in rabbits, inducing the
ormation of a semilunar valve construct. The authors re-
ived an old concept of tissue engineering for vascular
raftsE17 unfortunately prone to several complications, such
s early and late thrombosis as well as aneurysm formation.8
igure 1. Neural crest cells migrate to left ventricular outflow
ract, contributing to development of semilunar valves. LA, Left
trium; RA, right atrium; LV, left ventricle; RV, right ventricle. From
agmann M. A gene that scrambles your heart. Science. 1999;283:
091-3. Reprinted with permission of Nature Publishing Group. T
The Journal of Thoraclthough this technique may have several advantages in
roviding an autologous construct, conceptual questions
emain open. There were no hemodynamic forces to pro-
ram structural stimuli, so what were the type and arrange-
ent of collagen fibers, the mesostructure, and the whole
igure 2. A, Endoscopic view into sinus of Valsalva of pressur-
zed porcine aortic root. B, Inset of A, near annulus, strong
ollagen fibers bear thin, hammock-shaped membranes. C,
maller collagen fibers are embedded in these membranes (ar-
ows). D, This structural arrangement is shown histologically
fter fixation under load; red color indicates collagen. (Van Gie-
on staining courtesy W. Kühnel, Institute of Anatomy, University
f Luebeck, Luebeck, Germany.) E, Collagen fibers possess wavy,
rimped configuration (Fastenrath S. Texture of collagenous fi-
ers of the aortic/pulmonic valve [thesis]. Kiel, Germany: Univ. of
iel; 1995.). Reprinted with permission of Sven Fastenrath.
igure 3. Receptor-mediated contraction of aortic valve leaflets.
-HT, 5-Hydroxy-L-tryptophan. From Chester AH, Misfeld M, Ya-
oub MH. Receptor-mediated contraction of aortic valve leaflets.
Heart Valve Dis. 2000;9:250-5. Reprinted with permission from
he Journal of Heart Valve Disease.
ic and Cardiovascular Surgery ● Volume 134, Number 1 21
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Lpectrum of extracellular matrix components? Immunoreac-
ivity was not found for vimentin, contrary to normal aortic
alves.E12 Furthermore, how do the cells of this construct
hange their phenotype after coming into contact with pres-
ure and blood?E18 Finally, what is the durability of the
iovalve in circulation? Will thrombotic and aneurysmal
omplications occur even though the construct looks quite
nd promising? The underlying mechanism of this kind of
alve formation is probably more a foreign-body reaction
rying to encapsulate the artificial material rather than a true
evelopmental process. At any rate, the concept of in vivo
utologous tissue engineering with the patient as an autol-
gous “bioreactor” is undoubtedly appealing. Other ap-
roaches will follow, with more perfect molds or with a
ybrid technique that uses 4D biodegradable or nonbiode-
radable artificial, xenologous, or autologous scaffolds in an
nvironment simulating hemodynamic forces.
Newly promising principles of regenerative medicine,
ncluding tissue engineering and stem cell biology, are
ntering the field.E19 The less differentiated the stem cells,
he greater is their potential plasticity to develop into dif-
erent cells. To prevent uncontrolled, teratogenic differen-
iation, however, they need strategies of control, the right
timuli for structure, function, and time; something like a
lan. Furthermore, engineering technology develops rapidly
nd may contribute to tissue engineering or regenerative
edicine by providing, for example, biomimetic, anisotro-
ic, microscale, 3-dimensional, woven composite scaf-
olds,E20 ready to take over full load immediately, or even
ore sophisticated nanomembranes of organic-inorganic
nterpenetrating networks.E21 Recently, an artificial poly-
rotein with nanomechanical properties comparable to those
f naturally evolved elastomeric proteins was produced by
sing single-molecule atomic force microscopy tech-
iques.E22 In addition, interspecies comparison of evolution
ight add new and interesting knowledge. For example, the
odfish has two semilunar valves in series in the conus
rteriosus (Figure 4). Why? For depulsation? For stress
eduction?
Clearly, more basic research, stimulated by workshops
ike the recent National Institutes of Health workshop on
issue engineering in 2005, is mandatory to increase knowl-
dge in understanding biologic factors, especially the con-
rol of cell behavior, tissue function, aging, reparation,
egeneration, vascularization, remodeling, and decellular-
zation and recellularization of scaffolds. On the other hand,
ngineering factors including scaffold technology, nano-
echnology, protein design, computational and communicat-
ng technology, and tools for translation to tissue engineer-
ng will be developed. Clinical trials on this field should be
2 The Journal of Thoracic and Cardiovascular Surgery ● July 2arefully, prudently conducted and audit controlled. Suc-
esses—but also failures—should be published with a spirit
f cooperation in a “flattening” world,E23 and hopes should
e raised but not overstated.
As I write these lines, Michelangelo’s depiction of the
reation of Adam by God, depicted with a drapery looking
omething like the human brain, enters my mind. Let’s use
ur creativity and consciousness and try to get what we can.
he bar is set very high.
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